1. 1. Horie A, Koike D, Hirade T, Suemitsu K, Nariai A, Kitamura R, et al. Dramatic increase in the incidence of upper urinary tract infection caused by Extended-spectrum beta-lactamase- producing Escherichia coli in children in Izumo city. J Jpn Pediatr Soc. 2018;122:27-34.
2. 2. Nakamura T, Komatsu M, Yamasaki K, Fukuda S, Miyamoto Y, Higuchi T, et al. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan. Am J Clin Pathol. 2012;137:620-6. PMID:22431539, DOI:10.1309/AJCP48PDVKWQOXEZ
3. 3. Funaki S, Matsubara K, Sato T, Shimozono H, Okano R. Study of clinical efficacy of cefmetazole for commutinity-acquired periatric urinary tract infection. J Pediatr Infect Dis Immunol. 2021;33:7-14.
4. 4. Yoshikawa K, Moritake J, Suzuki K, Kira S, Koide H, Kiyota H, et al. Prevalence and drug-susceptibilities of extended-spectrum β -lactamase producing Escherichia coli strains isolated from urine. Jpn J Chemother. 2014;62:198-203.
5. 5. Tullus K, Shaikh N. Urinary tract infections in children. Lancet. 2020;395:1659-68. PMID:32446408, DOI:10.1016/S0140-6736(20)30676-0